Trademark: 97164613
Word
GENNEXT
Status
Registered
Status Code
700
Status Date
Tuesday, January 31, 2023
Serial Number
97164613
Registration Number
6967357
Registration Date
Tuesday, January 31, 2023
Mark Type
4000
Filing Date
Thursday, December 9, 2021
Published for Opposition
Tuesday, November 15, 2022

Trademark Owner History
GenNext Technologies, Inc. - Original Registrant

Classifications
9 Scientific apparatus and instruments and analysis apparatus and analysis instruments, namely, analytical apparatus for laboratory purposes for protein analysis, all for research, analysis and diagnosis purposes; laboratory analysis apparatus, namely, analytical apparatus for laboratory purposes for protein analysis using high energy plasma photolysis; imaging apparatus and instruments for use in the study of proteins in drug development, pharmaceutical research, biotechnology, biopharmaceutical and biosimilar research; Dosimeters, radical dosimeters, UV detectors, radical dosimeters for use in protein analysis; dosimeters for measuring hydroxyl radical concentration; dosimeters to provide real-time photometric absorbance measurements, enabling the assessment of effective hydroxyl radical concentration; downloadable computer software for protein analysis; downloadable computer software for analysis of protein higher order structure (HOS); downloadable computer software for processing data from hydroxyl radical protein footprinting (HRPF); downloadable computer software for use in drug discovery, pharmaceutical research, biotechnology, biopharmaceutical and biosimilar research
42 Scientific research; chemical research; biochemical research; technical consultancy and project planning in the field of biological research relating to proteins; research and development in the field of proteins for others; conducting scientific studies in the field of biomolecules and pharmaceuticals; conducting scientific studies in the field of proteins; conducting scientific studies in the field of high order structural protein analysis; conducting biosimilar-originator high order structural protein scientific studies; conducting expression platform high order structural protein scientific studies; conducting formulation high order structural protein scientific studies; conducting antibody-antigen epitope and paratope mapping for scientific purposes; conducting protein- ligand high order structural protein scientific studies; conducting protein-protein high order structural protein scientific studies; conducting receptor-drug high order structural protein scientific studies
GEN NEXT

Trademark Events
Jan 31, 2023
Notice Of Registration Confirmation Emailed
Jan 31, 2023
Registered-Principal Register
Nov 15, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 15, 2022
Published For Opposition
Oct 26, 2022
Notification Of Notice Of Publication E-Mailed
Oct 11, 2022
Approved For Pub - Principal Register
Oct 7, 2022
Teas/Email Correspondence Entered
Oct 6, 2022
Correspondence Received In Law Office
Oct 6, 2022
Teas Response To Office Action Received
Sep 21, 2022
Notification Of Non-Final Action E-Mailed
Sep 21, 2022
Non-Final Action E-Mailed
Sep 21, 2022
Non-Final Action Written
Sep 16, 2022
Assigned To Examiner
Dec 14, 2021
New Application Office Supplied Data Entered
Dec 13, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24